The fundamental role of endothelial cells in hantavirus pathogenesis

Frontiers in Microbiology

Volumn 5, Issue DEC, 2014, Pages

  Hepojoki, Jussi ^a   Vaheri, Antti ^a   Strandin, Tomas ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Bunyavirus; Endothelial dysfunction; Hantavirus; HCPS; HFRS

Indexed keywords

BETA INTERFERON; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; COMPLEMENT MEMBRANE ATTACK COMPLEX; DECAY ACCELERATING FACTOR; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GALECTIN 3; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 6; RANTES; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; UROKINASE RECEPTOR; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BLEEDING TIME; BLOOD VESSEL PERMEABILITY; CELL ACTIVATION; COMPLEMENT ACTIVATION; CYTOTOXIC T LYMPHOCYTE; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; HANTAVIRUS INFECTION; HEMATOPOIETIC CELL; HEMOSTASIS; HOST PATHOGEN INTERACTION; HUMORAL IMMUNITY; INFLAMMATION; LEUKOCYTOSIS; MACROPHAGE ACTIVATION; NATURAL KILLER CELL; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PATHOGENESIS; THROMBIN TIME; UPREGULATION;

BUNYAVIRIDAE; HANTAVIRUS; ORTHOBUNYAVIRUS; RODENTIA;

EID: 84920654248     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2014.00727     Document Type: Article

References (88)

1. Abel Borges, A., and Figueiredo, L. T. (2008). Mechanisms of shock in hantavirus pulmonary syndrome. Curr. Opin. Infect. Dis. 21, 293-297. doi: 10.1097/QCO.0b013e3282f88b6f
2. Antonen, J., Leppanen, I., Tenhunen, J., Arvola, P., Makela, S., Vaheri, A., et al. (2013). A severe case of puumala hantavirus infection successfully treated with bradykinin receptor antagonist icatibant. Scand. J. Infect. Dis. 45, 494-496. doi: 10.3109/00365548.2012.755268
3. Borges, A. A., Donadi, E. A., Campos, G. M., Moreli, M. L., de Sousa, R. L., Saggioro, F. P., et al. (2010). Association of -308G/A polymorphism in the tumor necrosis factor-alpha gene promoter with susceptibility to development of hantavirus cardiopulmonary syndrome in the ribeirao preto region, Brazil. Arch. Virol. 155, 971-975. doi: 10.1007/s00705-010-0655-7
4. Buranda, T., Wu, Y., Perez, D., Jett, S. D., BonduHawkins, V., Ye, C., et al. (2010). Recognition of decay accelerating factor and alpha(v)beta(3) by inactivated hantaviruses: toward the development of high-throughput screening flow cytometry assays. Anal. Biochem. 402, 151-160. doi: 10.1016/j.ab.2010.03.016
5. Cosgriff, T. M. (1991). Mechanisms of disease in hantavirus infection: pathophysiology of hemorrhagic fever with renal syndrome. Rev. Infect. Dis. 13, 97-107. doi: 10.1093/clinids/13.1.97
6. Duchin, J. S., Koster, F. T., Peters, C. J., Simpson, G. L., Tempest, B., Zaki, S. R., et al. (1994). Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study Group. N. Engl. J. Med. 330, 949-955. doi: 10.1056/NEJM199404073301401
7. Easterbrook, J. D., and Klein, S. L. (2008). Immunological mechanisms mediating hantavirus persistence in rodent reservoirs. PLoS Pathog. 4:e1000172. doi: 10.1371/journal.ppat.1000172
8. Eklund, L., and Saharinen, P. (2013). Angiopoietin signaling in the vasculature. Exp. Cell Res. 319, 1271-1280. doi: 10.1016/j.yexcr.2013.03.011
9. Engelmann, B., and Massberg, S. (2013). Thrombosis as an intravascular effector of innate immunity. Nat. Rev. Immunol. 13, 34-45. doi: 10.1038/nri3345
10. Gavrilovskaya, I., Gorbunova, E., Koster, F., and Mackow, E. (2012). Elevated VEGF levels in pulmonary edema fluid and PBMCs from patients with acute hantavirus pulmonary syndrome. Adv. Virol. 2012:674360. doi: 10.1155/2012/674360
11. Gavrilovskaya, I. N., Gorbunova, E. E., and Mackow, E. R. (2010). Pathogenic hantaviruses direct the adherence of quiescent platelets to infected endothelial cells. J. Virol. 84, 4832-4839. doi: 10.1128/JVI.02405-09
12. Gavrilovskaya, I. N., Gorbunova, E. E., Mackow, N. A., and Mackow, E. R. (2008). Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit hantavirus-directed permeability. J. Virol. 82, 5797-5806. doi: 10.1128/JVI.02397-07
13. Geimonen, E., LaMonica, R., Springer, K., Farooqui, Y., Gavrilovskaya, I. N., and Mackow, E. R. (2003). Hantavirus pulmonary syndrome-associated hantaviruses contain conserved and functional ITAM signaling elements. J. Virol. 77, 1638-1643. doi: 10.1128/JVI.77.2.1638-1643.2003
14. Guang, M. Y., Liu, G. Z., and Cosgriff, T. M. (1989). Hemorrhage in hemorrhagic fever with renal syndrome in china. Rev. Infect. Dis. 11(Suppl. 4), S884-S890. doi: 10.1093/clinids/11.Supplement_4.S844
15. Guivier, E., Galan, M., Salvador, A. R., Xuereb, A., Chaval, Y., Olsson, G. E., et al. (2010). Tnf-alpha expression and promoter sequences reflect the balance of tolerance/resistance to puumala hantavirus infection in european bank vole populations. Infect. Genet. Evol. 10, 1208-1217. doi: 10.1016/j.meegid.2010.07.022
16. Gupta, S., Braun, M., Tischler, N. D., Stoltz, M., Sundstrom, K. B., Bjorkstrom, N. K., et al. (2013). Hantavirus-infection confers resistance to cytotoxic lymphocyte-mediated apoptosis. PLoS Pathog. 9:e1003272. doi: 10.1371/journal.ppat.1003272
17. Han, Q., Zhang, L., Liu, Z., Kang, W., Lou, S., Qiu, J., et al. (2010). Elevated sICAM-1 levels in patients with hemorrhagic fever with renal syndrome caused by hantaan virus. Eur. J. Clin. Microbiol. Infect. Dis. 29, 1507-1511. doi: 10.1007/s10096-010-1032-x
18. Hepojoki, J., Strandin, T. M., Hetzel, U., Sironen, T., Klingstrom, J., Sane, J., et al. (2014). Acute hantavirus infection induces galectin-3-binding protein. J. Gen. Virol. 95(Pt 11), 2356-2364. doi: 10.1099/vir.0.066837-0
19. Huang, C., Jin, B., Wang, M., Li, E., and Sun, C. (1994). Hemorrhagic fever with renal syndrome: relationship between pathogenesis and cellular immunity. J. Infect. Dis. 169, 868-870. doi: 10.1093/infdis/169.4.868
20. Jonsson, C. B., Figueiredo, L. T., and Vapalahti, O. (2010). A global perspective on hantavirus ecology, epidemiology, and disease. Clin. Microbiol. Rev. 23, 412-441. doi: 10.1128/CMR.00062-09
21. Kanerva, M., Vaheri, A., Mustonen, J., and Partanen, J. (1998). High-producer allele of tumour necrosis factor-alpha is part of the susceptibility MHC haplotype in severe puumala virus-induced nephropathia epidemica. Scand. J. Infect. Dis. 30, 532-534. doi: 10.1080/00365549850161629
22. Kerr, H., and Richards, A. (2012). Complement-mediated injury and protection of endothelium: lessons from atypical haemolytic uraemic syndrome. Immunobiology 217, 195-203. doi: 10.1016/j.imbio.2011.07.028
23. Khaiboullina, S. F., Netski, D. M., Krumpe, P., and St Jeor, S. C. (2000). Effects of tumor necrosis factor alpha on sin nombre virus infection in vitro. J. Virol. 74, 11966-11971. doi: 10.1128/JVI.74.24.11966-11971.2000
24. Khaiboullina, S. F., Rizvanov, A. A., Lombardi, V. C., Morzunov, S. P., Reis, H. J., Palotas, A., et al. (2013). Andes-virus-induced cytokine storm is partially suppressed by ribavirin. Antivir. Ther. 18, 575-584. doi: 10.3851/IMP2524
25. Kilpatrick, E. D., Terajima, M., Koster, F. T., Catalina, M. D., Cruz, J., and Ennis, F. A. (2004). Role of specific CD8+ T cells in the severity of a fulminant zoonotic viral hemorrhagic fever, hantavirus pulmonary syndrome. J. Immunol. 172, 3297-3304. doi: 10.4049/jimmunol.172.5.3297
26. Kleinegris, M. C., Ten Cate-Hoek, A. J., and Ten Cate, H. (2012). Coagulation and the vessel wall in thrombosis and atherosclerosis. Pol. Arch. Med. Wewn. 122, 557-566.
27. Klempa, B., Koivogui, L., Sylla, O., Koulemou, K., Auste, B., Kruger, D. H., et al. (2010). Serological evidence of human hantavirus infections in guinea, West Africa. J. Infect. Dis. 201, 1031-1034. doi: 10.1086/651169
28. Klempa, B., Radosa, L., and Kruger, D. H. (2013). The broad spectrum of hantaviruses and their hosts in central europe. Acta Virol. 57, 130-137. doi: 10.4149/av_2013_02_130
29. Klempa, B., Witkowski, P. T., Popugaeva, E., Auste, B., Koivogui, L., Fichet-Calvet, E., et al. (2012). Sangassou virus, the first hantavirus isolate from Africa, displays genetic and functional properties distinct from those of other murinae-associated hantaviruses. J. Virol. 86, 3819-3827. doi: 10.1128/JVI.05879-11
30. Klingstrom, J., Plyusnin, A., Vaheri, A., and Lundkvist, A. (2002). Wild-type puumala hantavirus infection induces cytokines, C-reactive protein, creatinine, and nitric oxide in cynomolgus macaques. J. Virol. 76, 444-449. doi: 10.1128/JVI.76.1.444-449.2002
31. Korva, M., Duh, D., Saksida, A., Trilar, T., and Avsic-Zupanc, T. (2009). The hantaviral load in tissues of naturally infected rodents. Microbes Infect. 11, 344-351. doi: 10.1016/j.micinf.2008.12.016
32. Korva, M., Saksida, A., Kejzar, N., Schmaljohn, C., and Avsic-Zupanc, T. (2013). Viral load and immune response dynamics in patients with haemorrhagic fever with renal syndrome. Clin. Microbiol. Infect. 19, E358-E366. doi: 10.1111/1469-0691.12218
33. Kraus, A. A., Raftery, M. J., Giese, T., Ulrich, R., Zawatzky, R., Hippenstiel, S., et al. (2004). Differential antiviral response of endothelial cells after infection with pathogenic and nonpathogenic hantaviruses. J. Virol. 78, 6143-6150. doi: 10.1128/JVI.78.12.6143-6150.2004
34. Krautkramer, E., Grouls, S., Hettwer, D., Rafat, N., Tonshoff, B., and Zeier, M. (2014). Mobilization of circulating endothelial progenitor cells correlates with the clinical course of hantavirus disease. J. Virol. 88, 483-489. doi: 10.1128/JVI.02063-13
35. Krautkramer, E., Grouls, S., Stein, N., Reiser, J., and Zeier, M. (2011). Pathogenic old world hantaviruses infect renal glomerular and tubular cells and induce disassembling of cell-to-cell contacts. J. Virol. 85, 9811-9823. doi: 10.1128/JVI.00568-11
36. Krautkramer, E., and Zeier, M. (2008). Hantavirus causing hemorrhagic fever with renal syndrome enters from the apical surface and requires decay-accelerating factor (DAF/CD55). J. Virol. 82, 4257-4264. doi: 10.1128/JVI.02210-07
37. Kyriakidis, I., and Papa, A. (2013). Serum TNF-alpha, sTNFR1, IL-6, IL-8 and IL-10 levels in hemorrhagic fever with renal syndrome. Virus Res. 175, 91-94. doi: 10.1016/j.virusres.2013.03.020
38. Lahdevirta, J. (1971). Nephropathia epidemica in Finland. A clinical histological and epidemiological study. Ann. Clin. Res. 3, 1-54.
39. Lahdevirta, J. (1989). The minor problem of hemostatic impairment in nephropathia epidemica, the mild Scandinavian form of hemorrhagic fever with renal syndrome. Rev. Infect. Dis. 11(Suppl. 4), S860-S863. doi: 10.1093/clinids/11.Supplement_4.S860
40. Laine, O. K., Koskela, S. M., Outinen, T. K., Joutsi-Korhonen, L., Huhtala, H., Vaheri, A., et al. (2014). Plasma pentraxin-3 and coagulation and fibrinolysis variables during acute puumala hantavirus infection and associated thrombocytopenia. Blood Coagul. Fibrinolysis 25, 612-617.
41. Laine, O., Makela, S., Mustonen, J., Helminen, M., Vaheri, A., Lassila, R., et al. (2011). Platelet ligands and ADAMTS13 during puumala hantavirus infection and associated thrombocytopenia. Blood Coagul. Fibrinolysis 22, 468-472. doi: 10.1097/MBC.0b013e328346a420
42. Laine, O., Makela, S., Mustonen, J., Huhtala, H., Szanto, T., Vaheri, A., et al. (2010). Enhanced thrombin formation and fibrinolysis during acute puumala hantavirus infection. Thromb. Res. 126, 154-158. doi: 10.1016/j.thromres.2010.05.025
43. Lee, H. W. (1989). Hemorrhagic fever with renal syndrome in Korea. Rev. Infect. Dis. 11(Suppl. 4), S864-S876. doi: 10.1093/clinids/11.Supplement_4.S864
44. Lee, M., Kim, B. K., Kim, S., Park, S., Han, J. S., Kim, S. T., et al. (1989). Coagulopathy in hemorrhagic fever with renal syndrome (Korean hemorrhagic fever). Rev. Infect. Dis. 11(Suppl. 4), S877-S883. doi: 10.1093/clinids/11.Supplement_4.877
45. Li, W., and Klein, S. L. (2012). Seoul virus-infected rat lung endothelial cells and alveolar macrophages differ in their ability to support virus replication and induce regulatory T cell phenotypes. J. Virol. 86, 11845-11855. doi: 10.1128/JVI.01233-12
46. Linderholm, M., Ahlm, C., Settergren, B., Waage, A., and Tarnvik, A. (1996). Elevated plasma levels of tumor necrosis factor (TNF)-alpha, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome. J. Infect. Dis. 173, 38-43. doi: 10.1093/infdis/173.1.38
47. Lindgren, T., Ahlm, C., Mohamed, N., Evander, M., Ljunggren, H. G., and Bjorkstrom, N. K. (2011). Longitudinal analysis of the human T cell response during acute hantavirus infection. J. Virol. 85, 10252-10260. doi: 10.1128/JVI.05548-11
48. Ma, Y., Liu, B., Yuan, B., Wang, J., Yu, H., Zhang, Y., et al. (2012). Sustained high level of serum VEGF at convalescent stage contributes to the renal recovery after HTNV infection in patients with hemorrhagic fever with renal syndrome. Clin. Dev. Immunol. 2012:812386. doi: 10.1155/2012/812386
49. Mackow, E. R., and Gavrilovskaya, I. N. (2009). Hantavirus regulation of endothelial cell functions. Thromb. Haemost. 102, 1030-1041. doi: 10.1160/TH09-09-0640
50. Macneil, A., Nichol, S. T., and Spiropoulou, C. F. (2011). Hantavirus pulmonary syndrome. Virus Res. 162, 138-147. doi: 10.1016/j.virusres.2011.09.017
51. Makela, S., Hurme, M., Ala-Houhala, I., Mustonen, J., Koivisto, A. M., Partanen, J., et al. (2001). Polymorphism of the cytokine genes in hospitalized patients with puumala hantavirus infection. Nephrol. Dial. Transplant. 16, 1368-1373. doi: 10.1093/ndt/16.7.1368
52. Marcos-Ramiro, B., Garcia-Weber, D., and Millan, J. (2014). TNF-induced endothelial barrier disruption: beyond actin and rho. Thromb. Haemost. 112, 1088-1102. doi: 10.1160/TH14-04-0299
53. Matthys, V., and Mackow, E. R. (2012). Hantavirus regulation of type I interferon responses. Adv. Virol. 2012:524024. doi: 10.1155/2012/524024
54. Outinen, T. K., Makela, S., Huttunen, R., Maenpaa, N., Libraty, D., Vaheri, A., et al. (2014). Urine soluble urokinase-type plasminogen activator receptor levels correlate with proteinuria in puumala hantavirus infection. J. Intern. Med. 276, 387-395. doi: 10.1111/joim.12257
55. Outinen, T. K., Tervo, L., Makela, S., Huttunen, R., Maenpaa, N., Huhtala, H., et al. (2013). Plasma levels of soluble urokinase-type plasminogen activator receptor associate with the clinical severity of acute puumala hantavirus infection. PLoS ONE 8:e71335. doi: 10.1371/journal.pone.0071335
56. Paakkala, A., Mustonen, J., Viander, M., Huhtala, H., and Pasternack, A. (2000). Complement activation in nephropathia epidemica caused by puumala hantavirus. Clin. Nephrol. 53, 424-431.
57. Pensiero, M. N., Sharefkin, J. B., Dieffenbach, C. W., and Hay, J. (1992). Hantaan virus infection of human endothelial cells. J. Virol. 66, 5929-5936.
58. Penttinen, K., Lahdevirta, J., Kekomaki, R., Ziola, B., Salmi, A., Hautanen, A., et al. (1981). Circulating immune complexes, immunoconglutinins, and rheumatoid factors in nephropathia epidemica. J. Infect. Dis. 143, 15-21. doi: 10.1093/infdis/143.1.15
59. Peters, C. J., Simpson, G. L., and Levy, H. (1999). Spectrum of hantavirus infection: hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome. Annu. Rev. Med. 50, 531-545. doi: 10.1146/annurev.med.50.1.531
60. Popugaeva, E., Witkowski, P. T., Schlegel, M., Ulrich, R. G., Auste, B., Rang, A., et al. (2012). Dobrava-Belgrade hantavirus from germany shows receptor usage and innate immunity induction consistent with the pathogenicity of the virus in humans. PLoS ONE 7:e35587. doi: 10.1371/journal.pone.0035587
61. Raftery, M. J., Lalwani, P., Krautkrmer, E., Peters, T., Scharffetter-Kochanek, K., Kruger, R., et al. (2014). Beta2 integrin mediates hantavirus-induced release of neutrophil extracellular traps. J. Exp. Med. 211, 1485-1497. doi: 10.1084/jem.20131092
62. Rasmuson, J., Pourazar, J., Linderholm, M., Sandstrom, T., Blomberg, A., and Ahlm, C. (2011). Presence of activated airway T lymphocytes in human puumala hantavirus disease. Chest 140, 715-722. doi: 10.1378/chest.10-2791
63. Rondaij, M. G., Bierings, R., Kragt, A., van Mourik, J. A., and Voorberg, J. (2006). Dynamics and plasticity of weibel-palade bodies in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 26, 1002-1007. doi: 10.1161/01.ATV.0000209501.56852.6c
64. Sadeghi, M., Eckerle, I., Daniel, V., Burkhardt, U., Opelz, G., and Schnitzler, P. (2011). Cytokine expression during early and late phase of acute puumala hantavirus infection. BMC Immunol. 12:65. doi: 10.1186/1471-2172-12-65
65. Saksida, A., Wraber, B., and Avsic-Zupanc, T. (2011). Serum levels of inflammatory and regulatory cytokines in patients with hemorrhagic fever with renal syndrome. BMC Infect. Dis. 11:142. doi: 10.1186/1471-2334-11-142
66. Sane, J., Laine, O., Mäkelä, S., Paakkala, A., Jarva, H., Mustonen, J., et al. (2012). Complement activation in puumala hantavirus infection correlates with disease severity. Ann. Med. 44, 468-475. doi: 10.3109/07853890.2011.573500
67. Shrivastava-Ranjan, P., Rollin, P. E., and Spiropoulou, C. F. (2010). Andes virus disrupts the endothelial cell barrier by induction of vascular endothelial growth factor and downregulation of VE-cadherin. J. Virol. 84, 11227-11234. doi: 10.1128/JVI.01405-10
68. Spiropoulou, C. F., Albarino, C. G., Ksiazek, T. G., and Rollin, P. E. (2007). Andes and prospect hill hantaviruses differ in early induction of interferon although both can downregulate interferon signaling. J. Virol. 81, 2769-2776. doi: 10.1128/JVI.02402-06
69. Strandin, T., Hepojoki, J., Wang, H., Vaheri, A., and Lankinen, H. (2008). Hantaviruses and TNF-alpha act synergistically to induce ERK1/2 inactivation in vero E6 cells. Virol. J. 5:110. doi: 10.1186/1743-422X-5-110
70. Sundstrom, J. B., McMullan, L. K., Spiropoulou, C. F., Hooper, W. C., Ansari, A. A., Peters, C. J., et al. (2001). Hantavirus infection induces the expression of RANTES and IP-10 without causing increased permeability in human lung microvascular endothelial cells. J. Virol. 75, 6070-6085. doi: 10.1128/JVI.75.13.6070-6085.2001
71. Sundstrom, K. B., Stoltz, M., Lagerqvist, N., Lundkvist, A., Nemirov, K., and Klingstrom, J. (2011). Characterization of two substrains of puumala virus that show phenotypes that are different from each other and from the original strain. J. Virol. 85, 1747-1756. doi: 10.1128/JVI.01428-10
72. Takala, A., Lahdevirta, J., Jansson, S. E., Vapalahti, O., Orpana, A., Karonen, S. L., et al. (2000). Systemic inflammation in hemorrhagic fever with renal syndrome correlates with hypotension and thrombocytopenia but not with renal injury. J. Infect. Dis. 181, 1964-1970. doi: 10.1086/315522
73. Takano, T., Elimam, H., and Cybulsky, A. V. (2013). Complement-mediated cellular injury. Semin. Nephrol. 33, 586-601. doi: 10.1016/j.semnephrol.2013.08.009
74. Taylor, S. L., Wahl-Jensen, V., Copeland, A. M., Jahrling, P. B., and Schmaljohn, C. S. (2013). Endothelial cell permeability during hantavirus infection involves factor XII-dependent increased activation of the kallikrein-kinin system. PLoS Pathog. 9:e1003470. doi: 10.1371/journal.ppat.1003470
75. Terajima, M., and Ennis, F. A. (2011). T cells and pathogenesis of hantavirus cardiopulmonary syndrome and hemorrhagic fever with renal syndrome. Viruses 3, 1059-1073. doi: 10.3390/v3071059
76. Terajima, M., Hendershot, J. D.III, Kariwa, H., Koster, F. T., Hjelle, B., Goade, D., et al. (1999). High levels of viremia in patients with the hantavirus pulmonary syndrome. J. Infect. Dis. 180, 2030-2034. doi: 10.1086/315153
77. Tsai, T. F. (1987). Hemorrhagic fever with renal syndrome: clinical aspects. Lab. Anim. Sci. 37, 419-427.
78. Tsergouli, K., and Papa, A. (2013). Vascular endothelial growth factor levels in Dobrava/Belgrade virus infections. Viruses 5, 3109-3118. doi: 10.3390/v5123109
79. Ullrich, A., Sures, I., D'Egidio, M., Jallal, B., Powell, T. J., Herbst, R., et al. (1994). The secreted tumor-associated antigen 90K is a potent immune stimulator. J. Biol. Chem. 269, 18401-18407.
80. Vaheri, A., Mills, J. N., Spiropoulou, C. F., and Hjelle, B. (2011). "Hantaviruses," in Zoonoses - Biology, Clinical Practice and Public Health, 2nd Edn, eds S. R. Palmer, L. Soulsby, D. Brown, and P. Torgerson (Oxford: Oxford University Press), 307-322.
81. Vaheri, A., Strandin, T., Hepojoki, J., Sironen, T., Henttonen, H., Makela, S., et al. (2013). Uncovering the mysteries of hantavirus infections. Nat. Rev. Microbiol. 11, 539-550. doi: 10.1038/nrmicro3066
82. Vaheri, A., Strandin, T., Jaaskelainen, A. J., Vapalahti, O., Jarva, H., Lokki, M. L., et al. (2014). Pathophysiology of a severe case of puumala hantavirus infection successfully treated with bradykinin receptor antagonist icatibant. Antivir. Res. 111C, 23-25. doi: 10.1016/j.antiviral.2014.08.007
83. Valbuena, G., and Walker, D. H. (2006). The endothelium as a target for infections. Annu. Rev. Pathol. 1, 171-198. doi: 10.1146/annurev.pathol.1.110304.100031
84. Vapalahti, O., Kallio-Kokko, H., Narvanen, A., Julkunen, I., Lundkvist, A., Plyusnin, A., et al. (1995). Human B-cell epitopes of puumala virus nucleocapsid protein, the major antigen in early serological response. J. Med. Virol. 46, 293-303. doi: 10.1002/jmv.1890460402
85. Vapalahti, O., Lundkvist, A., and Vaheri, A. (2001). Human immune response, host genetics, and severity of disease. Curr. Top. Microbiol. Immunol. 256, 153-169. doi: 10.1007/978-3-642-56753-7_9
86. Wang, M., Wang, J., Zhu, Y., Xu, Z., Yang, K., Yang, A., et al. (2009). Cellular immune response to hantaan virus nucleocapsid protein in the acute phase of hemorrhagic fever with renal syndrome: correlation with disease severity. J. Infect. Dis. 199, 188-195. doi: 10.1086/595834
87. Yanagihara, R., and Silverman, D. J. (1990). Experimental infection of human vascular endothelial cells by pathogenic and nonpathogenic hantaviruses. Arch. Virol. 111, 281-286. doi: 10.1007/BF01311063
88. Zaki, S. R., Greer, P. W., Coffield, L. M., Goldsmith, C. S., Nolte, K. B., Foucar, K., et al. (1995). Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am. J. Pathol. 146, 552-579.